Clinical Trials Browser

Phase 1/2 × SCLC, Extensive Stage × Radiotherapy × Clear all

NCT06477523 2026-04-29

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

Phase 1/2 Active not recruiting

SCLC, Extensive Stage